-
1121
Hybrid azole-based conjugates as upcoming anticancer and antimicrobial agents
Published 2023-11-01“…The anticancer activity of the compounds was assessed through i) proliferation assays for HCT116, MCF-7, and A375 human cell lines [cells were treated with serial dilutions of compounds and the effect on cell propagation was evaluated by sulforhodamine B (SRB) assay]; ii) antiproliferative and cytotoxic assays for glioma-type cell lines A172 (glioblastoma), U87 (brain-likely glioblastoma), and H4 (neuroglioma; cells were treated with diverse concentrations and the cell viability was assessed using a modified Alamar blue® assay). …”
Get full text
Article -
1122
Outer retina micro-inflammation is driven by T cell responses prior to retinal degeneration in early age-related macular degeneration
Published 2025-02-01“…Importantly, the activation of T cells found at early AMD-like stages prior to degeneration possessed long-lasting cytotoxic properties and adopted typical features of senescent immune cells. …”
Get full text
Article -
1123
Metabolomics insights into doxorubicin and 5-fluorouracil combination therapy in triple-negative breast cancer: a xenograft mouse model study
Published 2025-01-01“…It significantly reduced critical metabolites such as guanine, xanthine, inosine, L-fucose, and sphinganine, demonstrating enhanced cytotoxic effects compared to individual treatments. …”
Get full text
Article -
1124
Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators
Published 2025-01-01“…A gene expression signature that is characteristic of CD4+ cytotoxic T lymphocytes (CD4-CTLs) was found to be elevated at baseline in non-responders to apheresis, although this could not be validated with statistical significance (n=19 MS patients).ConclusionOur data reveal that therapeutic apheresis in MS rapidly leads to a significant decrease in IgG reactivities against EBNA1 (391-410) and cross-reactive targets such as GlialCAM (370-389) and also has an impact on the gene expression of B cells and T cells. …”
Get full text
Article -
1125
VCP downstream metabolite glycerol-3-phosphate (G3P) inhibits CD8+T cells function in the HCC microenvironment
Published 2025-01-01“…Our findings reveal that VCP suppresses the activation, expansion, and cytotoxic capacity of CD8+T cells both in vitro and in vivo, significantly contributing to the immunosuppressive nature of the TME. …”
Get full text
Article -
1126
Congenital T-cell activation impairs transitional-to-follicular B-cell maturation in humans
Published 2025-02-01“…Abstract: Patients with cytotoxic T-lymphocyte–associated protein 4 (CTLA4) deficiency exhibit profound humoral immune dysfunction, yet the basis for the B-cell defect is not known. …”
Get full text
Article -
1127
Anti-Inflammatory Potential and Synergic Activities of <i>Eclipta prostrata</i> (L.) L. Leaf-Derived Ointment Formulation in Combination with the Non-Steroidal Anti-Inflammatory Dr...
Published 2024-12-01“…An MTT assay performed using L<sub>929</sub> cells proved that the extract has no cytotoxic effect. The plant extract displayed potential antibacterial activity against <i>Staphylococcus aureus</i>; the growth was inhibited at 1 mg/mL of <i>E. prostrata</i> extract. …”
Get full text
Article -
1128
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma
Published 2021-01-01“…Cell viability was reduced in a dose-dependent manner, with only the highest doses causing a cytotoxic effect associated with caspase 3/7 activation. …”
Get full text
Article -
1129
Immune checkpoint inhibitor-induced severe epidermal necrolysis mediated by macrophage-derived CXCL10 and abated by TNF blockade
Published 2024-12-01“…We examine 6 cohorts including 25 ICI-induced SJS/TEN patients and conduct single-cell RNA sequencing (scRNA-seq) analysis, which shows overexpression of macrophage-derived CXCL10 that recruits CXCR3+ cytotoxic T lymphocytes (CTL) in blister cells from ICI-SJS/TEN skin lesions. …”
Get full text
Article -
1130
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors
Published 2024-07-01“…IMA202 consists of autologous genetically modified cytotoxic CD8+ T cells expressing a T cell receptor (TCR), which is specific for a nine amino acid peptide derived from MAGEA1. …”
Get full text
Article -
1131
A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer
Published 2025-01-01“…Tumor-targeted VVL-m12 replicated to high levels, was cytotoxic in lung cancer cell lines. VVL-m12 demonstrated superior antitumor efficacy in subcutaneous lung cancer models compared with other VVs examined. …”
Get full text
Article -
1132
Uvaol attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells by modulating expression and membrane localization of β-catenin
Published 2025-01-01“…Uvaol had no significant cytotoxic effects on A549 cells. By contrast, the changes in the cell morphology consistent with TGF-β1-induced EMT were largely suppressed by treatment with uvaol. …”
Get full text
Article -
1133
Microbial metabolites and immune modulation
Published 2024-12-01“…Indole derivatives regulate natural killer (NK) cell activity, fine-tuning their cytotoxic responses and cytokine secretion to ensure the precise elimination of infected or malignant cells. …”
Get full text
Article -
1134
Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR
Published 2025-01-01“…EphA2‐specific CAR‐NK cells exhibit superior cytotoxicity against sarcoma cell lines in vitro and demonstrate significant anti‐tumour activity in in vivo mouse models of rhabdomyosarcoma and osteosarcoma. …”
Get full text
Article -
1135
A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer
Published 2024-12-01“…In pancreatic ductal adenocarcinoma (PDAC), where patient benefit from current cytotoxic therapy options is unsatisfactory, a close to uniform cell surface expression of CDH3 and TRAILR2 was observed, which will qualify the majority of PDAC patients for TR2/CDH3 BAB-based treatment. …”
Get full text
Article -
1136
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
Published 2025-02-01“…Patients received either a ''novel'' single agent (SA; 35%) or cytotoxic chemotherapy (CC; 60%) for their second-line treatment. …”
Get full text
Article -
1137
Cigarette and e-cigarette reversely regulated autophagy via distinct level of ROS in vitro
Published 2025-01-01“…With the increasing prevalence of e-cigarettes, a systematic evaluation of the cytotoxicity among the components of e-cigarettes is needed. …”
Get full text
Article -
1138
Baicalin and Baicalein Inhibit Src Tyrosine Kinase and Production of IL-6
Published 2016-01-01“…Baicalin and baicalein showed no signs of cytotoxicity in the MTS cytotoxicity assay in THP-1 cells.…”
Get full text
Article -
1139
Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
Published 2013-01-01“…We found a strong correlation between serum anti-AQP4 Ab concentration and complement-mediated cytotoxicity (P<0.0001). Nevertheless, neither relapse nor worsening of impairment level was closely associated with a significant increase in serum Ab concentration or cytotoxicity. …”
Get full text
Article -
1140
Uncovering NK cell sabotage in gut diseases via single cell transcriptomics.
Published 2025-01-01“…Natural killer (NK) cells from UC patients on medication showed reduced cytotoxicity compared to those from healthy individuals. …”
Get full text
Article